超越海马保护认知:记忆回避全脑放疗治疗脑转移瘤的2期试验剂量学结果
该2期试验纳入10例脑转移瘤>15个的患者,行记忆回避全脑放疗(MA-WBRT),勾画海马、杏仁核、胼胝体、穹窿并外扩5 mm形成回避区,处方30 Gy/10次。所有计划满足D100%≤9 Gy,8/10满足D0.03 cm3≤16 Gy,靶区覆盖与均匀性均达标。
要点
- MA-WBRT可保护海马、杏仁核、胼胝体及穹窿,同时保持靶区覆盖和均匀性。
- 所有计划满足D100%≤9 Gy,8/10计划满足D0.03 cm3≤16 Gy。
- 靶区覆盖D98%>25 Gy和均匀性D2%≤37.5 Gy在所有计划中均达成。
核心结论
- 现代容积调强弧形治疗技术可在良好靶区覆盖和均匀性下保护海马、杏仁核、胼胝体及穹窿。
- 入组完成后将评估生活质量和认知数据,以评价MA-WBRT减轻全脑放疗后生活质量和认知下降的疗效。
研究设计与样本
- 2期临床试验中连续纳入10例接受MA-WBRT的脑转移瘤患者进行剂量学分析。
- 处方剂量为30 Gy分10次,采用基于直线加速器的容积调强弧形治疗计划。
主要发现
- 记忆回避结构平均体积为37.1 cm3(范围25.2-44.6 cm3),占全脑靶区体积的2.5%。
- 所有计划满足D100%≤9 Gy,10例中8例满足D0.03 cm3≤16 Gy,其余2例优先保证肿瘤覆盖。
- 所有计划均达到靶区覆盖D98%>25 Gy和均匀性D2%≤37.5 Gy。
关键数值与推荐
- 回避结构剂量约束为D100%≤9 Gy和D0.03 cm3≤16 Gy(可接受变化至20 Gy)。
- 靶区覆盖要求D98%>25 Gy,均匀性要求D2%≤37.5 Gy。
- 记忆回避区由这些结构外扩5 mm形成,下丘脑和垂体避免热点。
临床怎么用
- 对于脑转移瘤>15个的患者,可考虑采用MA-WBRT以保护记忆相关结构。
- MA-WBRT计划设计时优先保证脑转移瘤覆盖,其次满足记忆回避剂量约束。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Recent advances to preserve neurocognitive function in patients treated for brain metastases include stereotactic radiosurgery, hippocampal avoidance whole brain radiation therapy (WBRT), and memantine administration. The hippocampus, corpus callosum, fornix, and amygdala are key neurocognitive substructures with a low propensity for brain metastases. Herein, we report our preliminary experience using a "memory-avoidance" WBRT (MA-WBRT) approach that spares these substructures for patients with >15 brain metastases. METHODS AND MATERIALS: Ten consecutive patients treated with MA-WBRT on a phase 2 clinical trial were reviewed. In each patient, the hippocampi, amygdalae, corpus callosum, and fornix were contoured. Patients were not eligible for MA-WBRT if they had metastases in these substructures. A memory-avoidance region was created using a 5-mm volumetric expansion around these substructures. Hotspots were avoided in the hypothalamus and pituitary gland. Coverage of brain metastases was prioritized over memory avoidance dose constraints. Dose constraints for these avoidance structures included a D100% ≤ 9 Gy and D0.03 cm3 ≤ 16 Gy (variation acceptable to 20 Gy). LINAC-based volumetric modulated arc therapy plans were generated for a prescription dose of 30 Gy in 10 fractions. RESULTS: On average, the memory avoidance structure volume was 37.1 cm3 (range, 25.2-44.6 cm3), occupying 2.5% of the entire whole brain target volume. All treatment plans met the D100% dose constraint, and 8 of 10 plans met the D0.03 cm3 constraint, with priority given to tumor coverage for the remaining 2 cases. Target coverage (D98% > 25 Gy) and homogeneity (D2% ≤ 37.5 Gy) were achieved for all plans. CONCLUSIONS: Modern volumetric modulated arc therapy techniques allow for sparing of the hippocampus, amygdala, corpus callosum, and fornix with good target coverage and homogeneity. After enrollment is completed, quality of life and cognitive data will be evaluated to assess the efficacy of MA-WBRT to mitigate declines in quality of life and cognition after whole brain radiation.
引用
- Perlow HK, Nalin AP, Ritter AR, et al. Advancing Beyond the Hippocampus to Preserve Cognition for Patients With Brain Metastases: Dosimetric Results From a Phase 2 Trial of Memory-Avoidance Whole Brain Radiation Therapy. Adv Radiat Oncol. 2023. PMID: 38405310. doi:10.1016/j.adro.2023.101337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。